Ciba-Geigy Vioform-hydrocortisone DESI hearing
Executive Summary
Fifth day of testimony was heard Nov. 18 from Ciba-Geigy witnesses, Howard Maibach, MD, University of California, San Francisco, and Henry Jolly, MD, Louisiana State University. According to Ciba-Geigy, the two dermatologists confirmed "their previous testimony that the efficacy of this combination product had been demonstrated by several adequate and well controlled clinical trials." The hearing began Nov. 6 and is scheduled to conclude on Dec. 4.